Cardiac Biomarkers Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ1005515 No. of Pages: 91 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Cardiac Biomarkers in Global, including the following market information:
Global Cardiac Biomarkers Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Cardiac Biomarkers market was valued at 724.6 million in 2020 and is projected to reach US$ 1016.7 million by 2027, at a CAGR of 8.8% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiac Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Biomarkers Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Cardiac Biomarkers Market Segment Percentages, By Type, 2020 (%)
Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others
China Cardiac Biomarkers Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Cardiac Biomarkers Market Segment Percentages, By Application, 2020 (%)
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
Global Cardiac Biomarkers Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Cardiac Biomarkers Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Cardiac Biomarkers Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Cardiac Biomarkers Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott
Abbott
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioMérieux
Bio-Rad Laboratories
BODITECH MED
1 Introduction to Research & Analysis Reports
1.1 Cardiac Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cardiac Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cardiac Biomarkers Overall Market Size
2.1 Global Cardiac Biomarkers Market Size: 2021 VS 2027
2.2 Global Cardiac Biomarkers Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiac Biomarkers Players in Global Market
3.2 Top Global Cardiac Biomarkers Companies Ranked by Revenue
3.3 Global Cardiac Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Biomarkers Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cardiac Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Biomarkers Players in Global Market
3.6.1 List of Global Tier 1 Cardiac Biomarkers Companies
3.6.2 List of Global Tier 2 and Tier 3 Cardiac Biomarkers Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cardiac Biomarkers Market Size Markets, 2021 & 2027
4.1.2 Troponin
4.1.3 CK-MB
4.1.4 Natriuretic Peptides - BNP and NT-proBNP
4.1.5 Myoglobin
4.1.6 Others
4.2 By Type - Global Cardiac Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Cardiac Biomarkers Revenue, 2016-2021
4.2.2 By Type - Global Cardiac Biomarkers Revenue, 2022-2027
4.2.3 By Type - Global Cardiac Biomarkers Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cardiac Biomarkers Market Size, 2021 & 2027
5.1.2 Acute Coronary Syndrome
5.1.3 Myocardial Infarction
5.1.4 Congestive Heart Failure
5.1.5 Others
5.2 By Application - Global Cardiac Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Cardiac Biomarkers Revenue, 2016-2021
5.2.2 By Application - Global Cardiac Biomarkers Revenue, 2022-2027
5.2.3 By Application - Global Cardiac Biomarkers Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Cardiac Biomarkers Market Size, 2021 & 2027
6.2 By Region - Global Cardiac Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Cardiac Biomarkers Revenue, 2016-2021
6.2.2 By Region - Global Cardiac Biomarkers Revenue, 2022-2027
6.2.3 By Region - Global Cardiac Biomarkers Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Cardiac Biomarkers Revenue, 2016-2027
6.3.2 US Cardiac Biomarkers Market Size, 2016-2027
6.3.3 Canada Cardiac Biomarkers Market Size, 2016-2027
6.3.4 Mexico Cardiac Biomarkers Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Cardiac Biomarkers Revenue, 2016-2027
6.4.2 Germany Cardiac Biomarkers Market Size, 2016-2027
6.4.3 France Cardiac Biomarkers Market Size, 2016-2027
6.4.4 U.K. Cardiac Biomarkers Market Size, 2016-2027
6.4.5 Italy Cardiac Biomarkers Market Size, 2016-2027
6.4.6 Russia Cardiac Biomarkers Market Size, 2016-2027
6.4.7 Nordic Countries Cardiac Biomarkers Market Size, 2016-2027
6.4.8 Benelux Cardiac Biomarkers Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Cardiac Biomarkers Revenue, 2016-2027
6.5.2 China Cardiac Biomarkers Market Size, 2016-2027
6.5.3 Japan Cardiac Biomarkers Market Size, 2016-2027
6.5.4 South Korea Cardiac Biomarkers Market Size, 2016-2027
6.5.5 Southeast Asia Cardiac Biomarkers Market Size, 2016-2027
6.5.6 India Cardiac Biomarkers Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Cardiac Biomarkers Revenue, 2016-2027
6.6.2 Brazil Cardiac Biomarkers Market Size, 2016-2027
6.6.3 Argentina Cardiac Biomarkers Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cardiac Biomarkers Revenue, 2016-2027
6.7.2 Turkey Cardiac Biomarkers Market Size, 2016-2027
6.7.3 Israel Cardiac Biomarkers Market Size, 2016-2027
6.7.4 Saudi Arabia Cardiac Biomarkers Market Size, 2016-2027
6.7.5 UAE Cardiac Biomarkers Market Size, 2016-2027
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Cardiac Biomarkers Major Product Offerings
7.1.4 Abbott Cardiac Biomarkers Revenue in Global (2016-2021)
7.1.5 Abbott Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Cardiac Biomarkers Major Product Offerings
7.2.4 Abbott Cardiac Biomarkers Revenue in Global (2016-2021)
7.2.5 Abbott Key News
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Corporate Summary
7.3.2 F. Hoffmann-La Roche Business Overview
7.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Major Product Offerings
7.3.4 F. Hoffmann-La Roche Cardiac Biomarkers Revenue in Global (2016-2021)
7.3.5 F. Hoffmann-La Roche Key News
7.4 Advanced ImmunoChemical
7.4.1 Advanced ImmunoChemical Corporate Summary
7.4.2 Advanced ImmunoChemical Business Overview
7.4.3 Advanced ImmunoChemical Cardiac Biomarkers Major Product Offerings
7.4.4 Advanced ImmunoChemical Cardiac Biomarkers Revenue in Global (2016-2021)
7.4.5 Advanced ImmunoChemical Key News
7.5 AgPlus Diagnostics
7.5.1 AgPlus Diagnostics Corporate Summary
7.5.2 AgPlus Diagnostics Business Overview
7.5.3 AgPlus Diagnostics Cardiac Biomarkers Major Product Offerings
7.5.4 AgPlus Diagnostics Cardiac Biomarkers Revenue in Global (2016-2021)
7.5.5 AgPlus Diagnostics Key News
7.6 BG Medicine
7.6.1 BG Medicine Corporate Summary
7.6.2 BG Medicine Business Overview
7.6.3 BG Medicine Cardiac Biomarkers Major Product Offerings
7.6.4 BG Medicine Cardiac Biomarkers Revenue in Global (2016-2021)
7.6.5 BG Medicine Key News
7.7 BioLegend
7.7.1 BioLegend Corporate Summary
7.7.2 BioLegend Business Overview
7.7.3 BioLegend Cardiac Biomarkers Major Product Offerings
7.4.4 BioLegend Cardiac Biomarkers Revenue in Global (2016-2021)
7.7.5 BioLegend Key News
7.8 bioMérieux
7.8.1 bioMérieux Corporate Summary
7.8.2 bioMérieux Business Overview
7.8.3 bioMérieux Cardiac Biomarkers Major Product Offerings
7.8.4 bioMérieux Cardiac Biomarkers Revenue in Global (2016-2021)
7.8.5 bioMérieux Key News
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Corporate Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Cardiac Biomarkers Major Product Offerings
7.9.4 Bio-Rad Laboratories Cardiac Biomarkers Revenue in Global (2016-2021)
7.9.5 Bio-Rad Laboratories Key News
7.10 BODITECH MED
7.10.1 BODITECH MED Corporate Summary
7.10.2 BODITECH MED Business Overview
7.10.3 BODITECH MED Cardiac Biomarkers Major Product Offerings
7.10.4 BODITECH MED Cardiac Biomarkers Revenue in Global (2016-2021)
7.10.5 BODITECH MED Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com